Clinical Trials

Showing trials with last updates posted in 2023.

NCT06121271 | NOT_YET_RECRUITING | PHASE2
110 participants

Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications

Study Type:
INTERVENTIONAL
Last Updated:
2023-12-07
Start Date:
2023-12-18
Completion:
2027-11-06
Conditions
  • Bronchial and Thymic Neuroendocrine Tumour
  • Paraganglioma/ Phaeochromocytoma
  • Medullary Thyroid Carcinoma
  • Those Requiring Repeat Peptide Receptor Radionuclide Therapy
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page